tm
Seeing Is Believing
tm
Seeing Is Believing
PCSA is currently covered by 3 analysts with an average price target of $-4.75. This is a potential upside of $-6.9 (-320.93%) from yesterday's end of day stock price of $2.15.
Processa Pharmaceuticals's activity chart (see below) currently has 2 price targets and 8 ratings on display. The stock rating distribution of PCSA is 83.33% BUY and 16.67% HOLD.
Analysts average stock forecasts to be materialized ratio is 100% with an average time for these price targets to be met of 226.67 days.
Highest price target for PCSA is $39, Lowest price target is $9, average price target is $-4.75.
Most recent stock forecast was given by NAZ RAHMAN from MAXIM GROUP on 17-Nov-2023. First documented stock forecast 08-Dec-2020.
Currently out of the existing stock ratings of PCSA, 5 are a BUY (83.33%), 1 are a HOLD (16.67%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
5
5 months 9 days ago
2/2 (100%)
$-8.2 (-62.12%)
98
Buy
4
$2.38 (146.91%)
9
1 years 22 days ago
2/2 (100%)
$-5.8 (-59.18%)
246
Buy
3
$1.38 (85.19%)
17
1 years 23 days ago
2/2 (100%)
$-6.7 (-69.07%)
336
What is PCSA (Processa Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on PCSA (Processa Pharmaceuticals) with a proven track record?
Which analyst has the current lower performing score on PCSA (Processa Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on PCSA (Processa Pharmaceuticals)?
Which analyst is the currently most bullish on PCSA (Processa Pharmaceuticals)?
Which analyst is the currently most reserved on PCSA (Processa Pharmaceuticals)?
